Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity.
Kearney SE, Gangano AJ, Barrus DG, Rehrauer KJ, Reid TR, Navaratne PV, Tracy EK, Roitberg A, Ghiviriga I, Cunningham CW, Gamage T, Grenning AJ. Kearney SE, et al. Among authors: reid tr. J Am Chem Soc. 2023 Jun 28;145(25):13581-13591. doi: 10.1021/jacs.3c00129. Epub 2023 Jun 14. J Am Chem Soc. 2023. PMID: 37314891 Free PMC article.
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors.
Conley AP, Roland CL, Bessudo A, Gastman BR, Villaflor VM, Larson C, Reid TR, Caroen S, Oronsky B, Stirn M, Williams J, Burbano E, Coyle A, Barve MA, Wagle N, Abrouk N, Kesari S. Conley AP, et al. Among authors: reid tr. Cancer Gene Ther. 2024 Apr;31(4):517-526. doi: 10.1038/s41417-023-00720-0. Epub 2023 Dec 25. Cancer Gene Ther. 2024. PMID: 38146006 Free PMC article. Clinical Trial.
Commentary on oncolytic viruses: past, present, and future.
Larson C, Oronsky B, Reid TR. Larson C, et al. Among authors: reid tr. J Immunother Cancer. 2023 Dec 21;11(12):e007905. doi: 10.1136/jitc-2023-007905. J Immunother Cancer. 2023. PMID: 38135348 Free PMC article.
TGF-β: the apex predator of immune checkpoints.
Oronsky B, Cabrales P, Alizadeh B, Caroen S, Stirn M, Williams J, Reid TR. Oronsky B, et al. Among authors: reid tr. Future Oncol. 2023 Sep;19(30):2013-2015. doi: 10.2217/fon-2023-0491. Epub 2023 Jul 28. Future Oncol. 2023. PMID: 37503560 Free article. No abstract available.
Data Management 101 for drug developers: A peek behind the curtain.
Oronsky B, Burbano E, Stirn M, Brechlin J, Abrouk N, Caroen S, Coyle A, Williams J, Cabrales P, Reid TR. Oronsky B, et al. Among authors: reid tr. Clin Transl Sci. 2023 Sep;16(9):1497-1509. doi: 10.1111/cts.13582. Epub 2023 Jul 6. Clin Transl Sci. 2023. PMID: 37382299 Free PMC article. Review.
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal Cancer.
Reid TR, Abrouk N, Caroen S, Oronsky B, Stirn M, Larson C, Beale K, Knox SJ, Fisher G. Reid TR, et al. Clin Colorectal Cancer. 2023 Mar;22(1):92-99. doi: 10.1016/j.clcc.2022.11.003. Epub 2022 Dec 2. Clin Colorectal Cancer. 2023. PMID: 36529613 Free article. Clinical Trial.
82 results